You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR COUMADIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for COUMADIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000469 ↗ Asymptomatic Carotid Artery Plaque Study (ACAPS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1988-05-01 To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk individuals with asymptomatic carotid stenosis. Also, to determine if a full scale trial was feasible.
NCT00003915 ↗ Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment Completed Dana-Farber Cancer Institute Phase 2 2004-03-01 The purpose of this study is to see if the combination of chemotherapy drugs and drugs to suppress testosterone (hormone therapy) is effective in controlling early prostate cancer. This study will attempt to: - stop or slow the growth of disease - gain information about prostate cancer - evaluate the effectiveness and side effects of the study drug
NCT00003915 ↗ Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment Completed University of Massachusetts, Worcester Phase 2 2004-03-01 The purpose of this study is to see if the combination of chemotherapy drugs and drugs to suppress testosterone (hormone therapy) is effective in controlling early prostate cancer. This study will attempt to: - stop or slow the growth of disease - gain information about prostate cancer - evaluate the effectiveness and side effects of the study drug
NCT00004054 ↗ Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer Completed National Cancer Institute (NCI) Phase 3 2000-01-01 RATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether hormone therapy plus radiation therapy is more effective with or without combination chemotherapy for prostate cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of hormone therapy plus radiation therapy with or without combination chemotherapy in treating patients who have prostate cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for COUMADIN

Condition Name

Condition Name for COUMADIN
Intervention Trials
Atrial Fibrillation 23
Healthy 7
Prostate Cancer 6
Venous Thrombosis 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for COUMADIN
Intervention Trials
Atrial Fibrillation 30
Thrombosis 24
Venous Thrombosis 17
Thromboembolism 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for COUMADIN

Trials by Country

Trials by Country for COUMADIN
Location Trials
United States 518
Canada 54
United Kingdom 35
Japan 31
China 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for COUMADIN
Location Trials
Texas 33
California 24
Florida 21
New York 20
Pennsylvania 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for COUMADIN

Clinical Trial Phase

Clinical Trial Phase for COUMADIN
Clinical Trial Phase Trials
Phase 4 31
Phase 3 23
Phase 2/Phase 3 4
[disabled in preview] 33
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for COUMADIN
Clinical Trial Phase Trials
Completed 85
Recruiting 13
Unknown status 11
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for COUMADIN

Sponsor Name

Sponsor Name for COUMADIN
Sponsor Trials
M.D. Anderson Cancer Center 14
Bristol-Myers Squibb 9
Genentech, Inc. 6
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for COUMADIN
Sponsor Trials
Other 183
Industry 73
NIH 15
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.